Published in Br J Dermatol on July 01, 2008
Retinoid metabolism is altered in human and mouse cicatricial alopecia. J Invest Dermatol (2012) 1.10
The pathogenesis of primary cicatricial alopecias. Am J Pathol (2010) 1.09
Lichen planopilaris treated with a peroxisome proliferator-activated receptor gamma agonist. Arch Dermatol (2009) 0.85
Successful Hair Transplant Outcome in Cicatricial Lichen Planus of the Scalp by Combining Scalp and Beard Hair Along With Platelet Rich Plasma. J Cutan Aesthet Surg (2016) 0.84
Primary cicatricial alopecia: diagnosis and treatment. CMAJ (2013) 0.82
The Role of Hair Restoration Surgery in Primary Cicatricial Alopecia. Skin Appendage Disord (2016) 0.75
A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol (2001) 6.12
Sonic hedgehog signaling is essential for hair development. Curr Biol (1998) 5.58
Controls of hair follicle cycling. Physiol Rev (2001) 5.49
British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009. Br J Dermatol (2009) 4.12
British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005. Br J Dermatol (2005) 3.10
Noggin is a mesenchymally derived stimulator of hair-follicle induction. Nat Cell Biol (1999) 2.99
Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev (2000) 2.98
Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis (2005) 2.61
Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut (2005) 2.36
A new look at scarring alopecia. Arch Dermatol (2000) 2.26
Effects of a cosmetic 'anti-ageing' product improves photoaged skin [corrected]. Br J Dermatol (2009) 2.25
Interleukin-15 protects from lethal apoptosis in vivo. Nat Med (1997) 2.22
Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling. FASEB J (2000) 2.09
Noggin is required for induction of the hair follicle growth phase in postnatal skin. FASEB J (2001) 1.95
Melanogenesis is coupled to murine anagen: toward new concepts for the role of melanocytes and the regulation of melanogenesis in hair growth. J Invest Dermatol (1993) 1.88
Analysis of apoptosis during hair follicle regression (catagen) Am J Pathol (1997) 1.82
Graying: gerontobiology of the hair follicle pigmentary unit. Exp Gerontol (2001) 1.75
Structural abnormalities of the hair shaft. J Am Acad Dermatol (1987) 1.75
A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction. Br J Dermatol (2005) 1.72
Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. Blood (1999) 1.71
Response of the hypothalamic-pituitary-adrenal axis to psychological stress in patients with psoriasis. Br J Dermatol (2005) 1.67
What are melanocytes really doing all day long...? Exp Dermatol (2009) 1.65
Retracted Death deflected: IL-15 inhibits TNF-alpha-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Ralpha chain. FASEB J (1999) 1.60
Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res (2010) 1.60
Tumour necrosis factor-alpha-induced migration of human Langerhans cells: the influence of ageing. Br J Dermatol (2002) 1.59
Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. J Lab Clin Med (1993) 1.58
Melanocytes as "sensory" and regulatory cells in the epidermis. J Theor Biol (1993) 1.55
Fumaric acid esters for severe psoriasis: a retrospective review of 58 cases. Br J Dermatol (2005) 1.49
Control of murine hair follicle regression (catagen) by TGF-beta1 in vivo. FASEB J (2000) 1.48
Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis. Ann Rheum Dis (2007) 1.47
Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease. J Med Genet (2007) 1.44
The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol (2000) 1.42
Geographical ancestry is a key determinant of epidermal morphology and dermal composition. Br J Dermatol (2014) 1.40
Failure of topical estrogen receptor agonists and antagonists to alter murine hair follicle cycling. J Invest Dermatol (1998) 1.40
Providing lifestyle behaviour change support for patients with psoriasis: an assessment of the existing training competencies across medical and nursing health professionals. Br J Dermatol (2014) 1.39
The 'melanocyte-keratin' mystery revisited: neither normal human epidermal nor hair follicle melanocytes express keratin 16 or keratin 6 in situ. Br J Dermatol (2009) 1.39
Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol (2008) 1.39
The TGF-beta2 isoform is both a required and sufficient inducer of murine hair follicle morphogenesis. Dev Biol (1999) 1.38
The role of the hairless (hr) gene in the regulation of hair follicle catagen transformation. Am J Pathol (1999) 1.38
Terra firme-forme dermatosis of the scalp. Br J Dermatol (2002) 1.38
Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Implications for paracrine and target-derived Neurotrophic functions. Am J Pathol (1999) 1.37
Making a 'point' about the safe disposal of sharps in patients on biological therapies. Br J Dermatol (2008) 1.37
Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma. Eur J Immunol (1998) 1.37
Alkaline phosphatase activity and localization during the murine hair cycle. Br J Dermatol (1994) 1.34
Molecular and functional aspects of the hairless (hr) gene in laboratory rodents and humans. Exp Dermatol (1998) 1.33
Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis? J Immunol (2000) 1.29
Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: selective review and hypothesis. Anticancer Res (1999) 1.29
Active hair growth (anagen) is associated with angiogenesis. J Invest Dermatol (2000) 1.29
Melanogenesis during the anagen-catagen-telogen transformation of the murine hair cycle. J Invest Dermatol (1994) 1.27
A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. Br J Dermatol (2002) 1.27
Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up. Br J Dermatol (2013) 1.26
Involvement of hepatocyte growth factor/scatter factor and met receptor signaling in hair follicle morphogenesis and cycling. FASEB J (2000) 1.26
Senile hair graying: H2O2-mediated oxidative stress affects human hair color by blunting methionine sulfoxide repair. FASEB J (2009) 1.25
Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol (2000) 1.25
Management of alopecia areata. BMJ (2010) 1.25
Differential expression and activity of melanogenesis-related proteins during induced hair growth in mice. J Invest Dermatol (1991) 1.24
Recognition of need in health care consultations: a qualitative study of people with psoriasis. Br J Dermatol (2012) 1.23
E- and P-cadherin expression during murine hair follicle morphogenesis and cycling. Exp Dermatol (1999) 1.22
Characterization of functional vanilloid receptors expressed by mast cells. Blood (1998) 1.21
Retracted The IL-15R alpha chain signals through association with Syk in human B cells. J Immunol (2001) 1.20
Hair cycle-dependent plasticity of skin and hair follicle innervation in normal murine skin. J Comp Neurol (1997) 1.20
Cutaneous expression of CRH and CRH-R. Is there a "skin stress response system?". Ann N Y Acad Sci (1999) 1.18
Hair follicle expression of 1,25-dihydroxyvitamin D3 receptors during the murine hair cycle. Br J Dermatol (1994) 1.18
Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. Br J Dermatol (2003) 1.17
Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia. Am J Pathol (1997) 1.17
Adherence to medication in patients with psoriasis: a systematic literature review. Br J Dermatol (2013) 1.14
What causes alopecia areata? Exp Dermatol (2013) 1.14
Environmental risk factors for the development of psoriatic arthritis: results from a case-control study. Ann Rheum Dis (2007) 1.13
Differential contribution of CDKAL1 variants to psoriasis, Crohn's disease and type II diabetes. Genes Immun (2009) 1.12
The role of neuropeptides in psoriasis. Br J Dermatol (2006) 1.12
Treatment of erythema nodosum and nodular vasculitis with potassium iodide. Br J Dermatol (1976) 1.11
Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks. Br J Dermatol (2005) 1.11
Adherence to treatment in patients with psoriasis. J Eur Acad Dermatol Venereol (2006) 1.11
Inpatient management of psoriasis: a multicentre service review to establish national admission standards. Br J Dermatol (2007) 1.10
Natural killer and natural killer-T cells in psoriasis. Arch Dermatol Res (2002) 1.09
Interventions for chronic palmoplantar pustulosis. Cochrane Database Syst Rev (2006) 1.09
Striae gravidarum in primiparae. Br J Dermatol (2006) 1.08
Towards defining the pathogenesis of the hairless phenotype. J Invest Dermatol (1998) 1.06
Treatment of chromoblastomycosis with high local concentrations of amphotericin B. Br J Dermatol (1967) 1.06
Distinct patterns of NCAM expression are associated with defined stages of murine hair follicle morphogenesis and regression. J Histochem Cytochem (1998) 1.05
Proopiomelanocortin expression in the skin during induced hair growth in mice. Experientia (1992) 1.05
Guideline for anti-TNF-alpha therapy in psoriatic arthritis. Rheumatology (Oxford) (2005) 1.05
Discoid lupus alopecia complicated by frontal fibrosing alopecia on a background of androgenetic alopecia. Br J Dermatol (2013) 1.04
Circulating natural killer cells in psoriasis. Br J Dermatol (2003) 1.04
On the potential role of proopiomelanocortin in skin physiology and pathology. Mol Cell Endocrinol (1993) 1.04
Detection of psychological distress in patients with psoriasis: low consensus between dermatologist and patient. Br J Dermatol (2004) 1.04
Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin. Br J Dermatol (2006) 1.04
Evidence that the bulge region is a site of relative immune privilege in human hair follicles. Br J Dermatol (2008) 1.03
IL-1beta-induced Langerhans' cell migration and TNF-alpha production in human skin: regulation by lactoferrin. Clin Exp Immunol (2003) 1.03
Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial. Br J Dermatol (2005) 1.03
Keratin 17 gene expression during the murine hair cycle. J Invest Dermatol (1997) 1.03
Merkel cells in mouse skin: intermediate filament pattern, localization, and hair cycle-dependent density. J Invest Dermatol (1996) 1.02
Patterns of proliferation and apoptosis during murine hair follicle morphogenesis. J Invest Dermatol (2001) 1.02
Human hair histogenesis for the mitochondrial DNA forensic scientist. J Forensic Sci (2001) 1.01
Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies. Br J Dermatol (2011) 1.00
Patterns of hairless (hr) gene expression in mouse hair follicle morphogenesis and cycling. Am J Pathol (2000) 1.00
The major psoriasis susceptibility locus PSORS1 is not a risk factor for late-onset psoriasis. J Invest Dermatol (2005) 1.00
Mutant laboratory mice with abnormalities in hair follicle morphogenesis, cycling, and/or structure: annotated tables. Exp Dermatol (2001) 1.00